A. Oliff

Tumor necrosis factor not detectable in patients with clinical cancer cachexia.

J. Kuhn, S. H. Socher, J. Craig, 1988, Journal of the National Cancer Institute.

Transforming Growth Factor-& Mullerian Inhibiting Substance Fiannily of Growth Regulators

Margaret A. Liu, A. Oliff, 1991 .

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.

J. Shiver, K. Leander, J. Ulmer, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.

P. Donahoe, D. V. Von Hoff, R. Hoffman, 1989, Cancer research.

A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

J. Donnelly, R. Deck, A. Friedman, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Transforming growth factor-beta--mullerian inhibiting substance family of growth regulators.

M. A. Liu, A. Oliff, M. Liu, 1991, Cancer investigation.

Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.

V. Garsky, J. Quintero, M. W. Riemen, 1987, Proceedings of the National Academy of Sciences of the United States of America.